B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

VDR

MOLECULAR TARGET

vitamin D receptor

UniProt: BAH02291NCBI Gene: 742179 compounds

VDR (vitamin D receptor) is targeted by 79 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting VDR

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Calcitriol4.65104
2Lithocholic Acid2.5612
3Cholecalciferol Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of1.956
4Disulfiram1.614
5Ethidium1.614
6Oxyphenbutazone1.614
7Dactinomycin1.393
8Nisoldipine1.393
9Apigenin 5,7,4'-trihydroxy-flavone,1.102
10Arachidonic Acid1.102
11Dehydroepiandrosterone Sulfate1.102
12plumbagin [Supplementary Concept]1.102
13alpha-Linolenic Acid1.102
14Dinitrochlorobenzene1.102
15Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone1.102
16Idazoxan1.102
17juglone hydroxylase [Supplementary Concept] catalyzes1.102
18Vitamin K 31.102
19Podophyllotoxin1.102
20Sodium Dodecyl Sulfate1.102
21Wortmannin1.102
22Catechin0.691
23chrysin0.691
24Night Vision Function of0.691
25Methotrexate0.691
26Amoxapine0.691
27Aurintricarboxylic Acid0.691
28Bromocriptine0.691
29C75-coenzyme0.691
30Calcifediol0.691
31Calcimycin0.691
32candesartan cilexetil [Supplementary Concept]0.691
33Carbaryl0.691
34salvin [Supplementary Concept]0.691
35cefaclor0.691
36Cefpirome0.691
37Colchicine0.691
38cycloheximide0.691
39d6090.691
40Daunorubicin0.691
41diallyl trisulfide0.691
42Diamide0.691
43Edaravone0.691
44Emetine0.691
45Epinephrine0.691
46Estramustine0.691
47Ethoxyquin Antioxidant; also0.691
48Feprazone0.691
49gamma-Linolenic Acid0.691
50Gliotoxin0.691

Showing top 50 of 79 compounds. Use the BiohacksAI search to explore all VDR modulators.

About VDR as a Drug Target

VDR (vitamin D receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 79 compounds with documented VDR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

VDR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.